Minor hamstring injuries account for half the time that European football players spend on the bench.

The CALYPSO trial compared CA-125 testing to imaging studies. Another trial finds value in a KRAS variant in judging chemotherapy resistance.

An easier option for treating diabetes in depression, but bad news for those who have it.

Does the rotavirus vaccine in increase the risk? Both CDC and FDA warn about the risk of recurrent intussusception, but an analysis of hospital records gives reassurance.

Appropriate treatment helps about one in four patients to achieve meaningful outcomes.

Although a recent study found disappointing results for the combination, there are reasons for optimism about both drugs individually.

A joint ACC-AHA task force has defined the key clinical data standards for peripheral atherosclerotic vascular disease.

Observers draw attention to the obstacles -- clinical, financial, and regulatory -- that hinder development of new drugs for rare cancers.

The worse the damage to the kidney, and the earlier the onset, the greater the risks of heart attack.

Can the newer technology challenge fixed-beam IMRT for assessing these cancers?